NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 22 04:00PM ET
15.88
Dollar change
+0.77
Percentage change
5.10
%
IndexRUT P/E- EPS (ttm)-4.10 Insider Own1.50% Shs Outstand87.45M Perf Week7.08%
Market Cap1.41B Forward P/E15.63 EPS next Y1.02 Insider Trans-15.77% Shs Float87.44M Perf Month-22.65%
Income-321.55M PEG- EPS next Q-0.55 Inst Own109.06% Short Float13.22% Perf Quarter-18.40%
Sales233.18M P/S6.05 EPS this Y68.73% Inst Trans20.97% Short Ratio6.43 Perf Half Y-12.99%
Book/sh0.68 P/B23.51 EPS next Y179.64% ROA-46.37% Short Interest11.56M Perf Year173.79%
Cash/sh4.18 P/C3.80 EPS next 5Y- ROE-246.75% 52W Range5.12 - 25.29 Perf YTD-8.84%
Dividend Est.- P/FCF- EPS past 5Y-3.34% ROI-83.18% 52W High-37.21% Beta0.97
Dividend TTM- Quick Ratio2.04 Sales past 5Y13.83% Gross Margin78.00% 52W Low210.16% ATR (14)1.19
Dividend Ex-Date- Current Ratio2.08 EPS Y/Y TTM10.01% Oper. Margin-109.87% RSI (14)44.23 Volatility5.16% 7.64%
Employees385 Debt/Eq6.80 Sales Y/Y TTM17.27% Profit Margin-137.90% Recom1.13 Target Price34.50
Option/ShortYes / Yes LT Debt/Eq5.54 EPS Q/Q38.54% Payout- Rel Volume0.71 Prev Close15.11
Sales Surprise0.64% EPS Surprise-29.89% Sales Q/Q65.98% EarningsFeb 20 AMC Avg Volume1.80M Price15.88
SMA20-3.34% SMA50-16.76% SMA200-1.40% Trades Volume1,277,972 Change5.10%
Date Action Analyst Rating Change Price Target Change
Jan-10-25Initiated Cantor Fitzgerald Overweight
Oct-21-24Upgrade Wells Fargo Equal Weight → Overweight $9 → $27
Oct-16-24Initiated Scotiabank Sector Outperform
Sep-09-24Upgrade Guggenheim Neutral → Buy $25
Mar-27-24Downgrade Guggenheim Buy → Neutral
Dec-05-23Upgrade Citigroup Neutral → Buy $7 → $10
Nov-20-23Initiated Citigroup Neutral $7
Sep-22-23Downgrade Wells Fargo Overweight → Equal Weight $24 → $8
Sep-21-23Downgrade William Blair Outperform → Mkt Perform
Sep-06-23Resumed Evercore ISI Outperform $30
Apr-12-25 10:20AM
Apr-11-25 05:00PM
Apr-07-25 03:27AM
Mar-31-25 04:30PM
Mar-30-25 03:50AM
02:50AM Loading…
02:50AM
Mar-26-25 09:39PM
07:00AM
Mar-17-25 07:01AM
Mar-12-25 05:30PM
Feb-24-25 04:30PM
Feb-23-25 03:03PM
Feb-22-25 09:20AM
Feb-20-25 04:01PM
09:06AM
02:06PM Loading…
Feb-14-25 02:06PM
Feb-13-25 04:30PM
10:31AM
Feb-12-25 05:30PM
Feb-11-25 07:01AM
Jan-13-25 07:00AM
Jan-06-25 04:30PM
Dec-03-24 05:51AM
Nov-25-24 04:30PM
Nov-13-24 05:00PM
Nov-12-24 04:05PM
Nov-07-24 09:05PM
04:01PM
07:00AM
Nov-04-24 04:30PM
03:05AM Loading…
Nov-01-24 03:05AM
Oct-31-24 07:00AM
Oct-30-24 09:13AM
Oct-28-24 08:35AM
Oct-26-24 07:01AM
Oct-21-24 04:30PM
Oct-17-24 07:01AM
02:30AM
Oct-14-24 04:30PM
Oct-09-24 03:50PM
08:02AM
Sep-26-24 04:01PM
Sep-12-24 05:00PM
Sep-10-24 04:01PM
Sep-06-24 09:20AM
Sep-05-24 05:34PM
Aug-22-24 04:30PM
Aug-06-24 04:30PM
Aug-01-24 04:01PM
Jul-25-24 04:30PM
Jul-10-24 08:43AM
Jul-08-24 04:30PM
Jun-24-24 07:32AM
Jun-11-24 05:00PM
May-15-24 05:00PM
May-09-24 04:30PM
May-08-24 04:30PM
01:22PM
May-07-24 11:29AM
03:07AM
May-06-24 08:59PM
05:30PM
05:10PM
04:01PM
Apr-29-24 04:30PM
Apr-24-24 07:05AM
03:00AM
Apr-04-24 04:30PM
Apr-03-24 04:30PM
Mar-13-24 05:00PM
Mar-11-24 07:05AM
Feb-26-24 04:30PM
Feb-23-24 07:05AM
02:00AM
Feb-16-24 09:52AM
Feb-15-24 04:01PM
Feb-08-24 04:30PM
Feb-01-24 04:30PM
Jan-25-24 04:05PM
Jan-08-24 07:00AM
Jan-02-24 04:30PM
Dec-14-23 07:30AM
Dec-04-23 04:05PM
Nov-21-23 04:30PM
Nov-09-23 06:26PM
Nov-07-23 04:01PM
Nov-03-23 10:46AM
Oct-24-23 04:30PM
Oct-13-23 04:30PM
Oct-11-23 05:00PM
Sep-26-23 04:30PM
Sep-22-23 09:38AM
Sep-21-23 07:30AM
Sep-11-23 05:00PM
Sep-05-23 08:30AM
08:30AM
Aug-31-23 04:30PM
Aug-24-23 04:30PM
Aug-14-23 05:00PM
Aug-08-23 06:03AM
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cline Christopher R.CHIEF FINANCIAL OFFICERApr 11 '25Sale13.144863189,990Apr 14 06:23 PM
Christopher ClineOfficerApr 11 '25Proposed Sale13.1448631Apr 11 07:03 PM
ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&DFeb 12 '25Sale23.535,200122,35698,519Feb 12 09:30 PM
REED ELIZABETH ESVP, GC & CORPORATE SECRETARYFeb 12 '25Sale23.538,000188,24089,482Feb 12 09:28 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERFeb 11 '25Option Exercise16.6345,000748,20078,654Feb 12 09:27 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERFeb 11 '25Sale25.0054,2441,356,10054,410Feb 12 09:27 PM
Heerma PeterCHIEF COMMERCIAL OFFICERFeb 11 '25Sale25.003,07476,850127,634Feb 12 09:25 PM
Heerma PeterCHIEF COMMERCIAL OFFICERFeb 12 '25Sale23.532,56860,426125,066Feb 12 09:25 PM
Dube Eric MCHIEF EXECUTIVE OFFICERFeb 11 '25Sale24.0411,375273,455419,173Feb 12 09:23 PM
Inrig JulaCHIEF MEDICAL OFFICERFeb 12 '25Sale23.532,56860,42689,602Feb 12 09:22 PM
Peter HeermaOfficerFeb 12 '25Proposed Sale23.532,56860,426Feb 12 07:47 PM
Jula InrigOfficerFeb 12 '25Proposed Sale23.532,56860,426Feb 12 07:46 PM
ROTE WILLIAM E.OfficerFeb 12 '25Proposed Sale23.535,200122,356Feb 12 11:03 AM
REED ELIZABETH EOfficerFeb 12 '25Proposed Sale23.538,000188,240Feb 12 09:52 AM
SANDRA CALVINOfficerFeb 11 '25Proposed Sale25.0054,2441,356,100Feb 11 04:08 PM
PETER HEERMAOfficerFeb 11 '25Proposed Sale25.003,07476,850Feb 11 04:04 PM
Dube Eric MOfficerFeb 11 '25Proposed Sale24.0411,375273,455Feb 11 11:56 AM
Baynes Roy D.DirectorFeb 06 '25Option Exercise17.4410,000174,40041,000Feb 10 06:04 PM
Baynes Roy D.DirectorFeb 06 '25Sale22.0010,000220,00031,000Feb 10 06:04 PM
ROY D BAYNESDirectorFeb 06 '25Proposed Sale22.0010,000220,000Feb 06 04:21 PM
ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&DFeb 03 '25Sale19.788,951177,05195,719Feb 04 08:30 PM
REED ELIZABETH ESVP, GC & CORPORATE SECRETARYFeb 03 '25Sale19.788,951177,05189,482Feb 04 08:30 PM
Dube Eric MCHIEF EXECUTIVE OFFICERFeb 03 '25Sale20.2150,6911,024,343430,548Feb 04 08:30 PM
Inrig JulaCHIEF MEDICAL OFFICERFeb 03 '25Sale20.124,20784,64585,236Feb 04 08:30 PM
Inrig JulaCHIEF MEDICAL OFFICERFeb 04 '25Sale20.111,06621,43784,170Feb 04 08:30 PM
Heerma PeterCHIEF COMMERCIAL OFFICERFeb 03 '25Sale20.125,166103,940122,708Feb 04 08:30 PM
Cline Christopher R.CHIEF FINANCIAL OFFICERFeb 03 '25Sale20.125,192104,46390,038Feb 04 08:30 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERFeb 03 '25Sale20.123,34867,36263,654Feb 04 08:30 PM
JULA INRIGOfficerFeb 04 '25Proposed Sale20.111,06621,437Feb 04 04:11 PM
Peter HeermaOfficerFeb 03 '25Proposed Sale20.125,166103,934Feb 03 08:47 PM
Christopher ClineOfficerFeb 03 '25Proposed Sale20.125,192104,457Feb 03 08:46 PM
Sandra CalvinOfficerFeb 03 '25Proposed Sale20.123,34867,358Feb 03 08:41 PM
Jula InrigOfficerFeb 03 '25Proposed Sale20.124,20784,640Feb 03 08:40 PM
REED ELIZABETH EOfficerFeb 03 '25Proposed Sale19.788,951177,051Feb 03 12:26 PM
Dube Eric MOfficerFeb 03 '25Proposed Sale19.7850,6911,002,668Feb 03 11:22 AM
ROTE WILLIAM E.OfficerFeb 03 '25Proposed Sale19.788,951177,051Feb 03 11:11 AM
ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&DJan 22 '25Sale19.462,43747,42483,170Jan 23 08:40 PM
Dube Eric MCHIEF EXECUTIVE OFFICERJan 22 '25Sale19.4610,736208,923351,239Jan 23 08:39 PM
REED ELIZABETH ESVP, GC & CORPORATE SECRETARYJan 22 '25Sale19.462,43747,42476,933Jan 23 08:37 PM
Baynes Roy D.DirectorJan 23 '25Option Exercise17.5016,000280,00047,000Jan 23 08:36 PM
Baynes Roy D.DirectorJan 23 '25Sale20.0016,000320,00031,000Jan 23 08:36 PM
Heerma PeterCHIEF COMMERCIAL OFFICERJan 22 '25Sale18.941,58430,002106,374Jan 23 08:35 PM
Cline Christopher R.CHIEF FINANCIAL OFFICERJan 22 '25Sale18.9486516,38473,730Jan 23 08:33 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERJan 22 '25Sale18.9492517,52054,002Jan 23 08:31 PM
ROY D BAYNESDirectorJan 23 '25Proposed Sale20.0016,000320,000Jan 23 04:14 PM
Dube Eric MOfficerJan 22 '25Proposed Sale19.4610,736208,923Jan 22 10:34 AM
REED ELIZABETH EOfficerJan 22 '25Proposed Sale19.462,43747,424Jan 22 10:18 AM
ROTE WILLIAM E.OfficerJan 22 '25Proposed Sale19.462,43747,424Jan 22 09:36 AM
Inrig JulaCHIEF MEDICAL OFFICERJan 03 '25Sale19.102,06639,46159,883Jan 06 07:21 PM
Inrig JulaCHIEF MEDICAL OFFICERJan 06 '25Sale18.764408,25459,443Jan 06 07:21 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERDec 26 '24Option Exercise12.6715,000190,05069,927Dec 27 07:47 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERDec 26 '24Sale17.2215,000258,27754,927Dec 27 07:47 PM
SANDRA CALVINOfficerDec 26 '24Proposed Sale17.2215,000258,278Dec 26 04:13 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERNov 25 '24Option Exercise12.6715,000190,05067,017Nov 25 09:00 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERNov 25 '24Sale18.3012,090221,25854,927Nov 25 09:00 PM
Calvin SandraOfficerNov 25 '24Proposed Sale18.3012,090221,258Nov 25 05:59 PM
LYONS GARY ADirectorOct 04 '24Option Exercise10.4840,000419,20091,000Oct 04 07:15 PM
LYONS GARY ADirectorOct 04 '24Sale14.7340,000589,10151,000Oct 04 07:15 PM
GARY A LYONSOfficerOct 04 '24Proposed Sale13.6540,000546,000Oct 04 04:21 PM
Meckler Jeffrey ADirectorSep 30 '24Option Exercise10.4840,000419,200121,000Sep 30 08:38 PM
Meckler Jeffrey ADirectorSep 30 '24Sale14.0640,000562,32481,000Sep 30 08:38 PM
JEFFREY MECKLERDirectorSep 30 '24Proposed Sale14.0640,000562,324Sep 30 04:22 PM
Calvin SandraOfficerSep 11 '24Proposed Sale14.8015,000222,000Sep 11 06:29 PM
Inrig JulaCHIEF MEDICAL OFFICERSep 10 '24Sale12.986848,87861,949Sep 10 04:05 PM
ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&DSep 09 '24Sale11.524,38750,53884,455Sep 09 09:20 PM
REED ELIZABETH ESVP, GC & CORPORATE SECRETARYSep 09 '24Sale11.524,38750,53878,633Sep 09 09:20 PM
Dube Eric MCHIEF EXECUTIVE OFFICERSep 09 '24Sale11.5221,125243,360361,975Sep 09 09:20 PM
Inrig JulaCHIEF MEDICAL OFFICERSep 09 '24Sale11.522,19125,24062,633Sep 09 09:20 PM
Heerma PeterCHIEF COMMERCIAL OFFICERSep 09 '24Sale11.522,19125,240107,958Sep 09 09:20 PM
Cline Christopher R.CHIEF FINANCIAL OFFICERSep 09 '24Sale11.522,49028,68574,595Sep 09 09:20 PM
REED ELIZABETH EOfficerSep 09 '24Proposed Sale11.524,38750,538Sep 09 10:54 AM
ROTE WILLIAM E.OfficerSep 09 '24Proposed Sale11.524,38750,538Sep 09 10:35 AM
Dube Eric MOfficerSep 09 '24Proposed Sale11.5221,125243,360Sep 09 10:34 AM
Cline Christopher R.CHIEF FINANCIAL OFFICERSep 04 '24Sale9.515144,88870,335Sep 05 09:30 PM